Cargando…
A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I)
Hyperimmune globulin (HIG) has shown efficacy against human cytomegalovirus (HCMV) for both transplant and congenital transmission indications. Replicating that activity with a monoclonal antibody (mAb) offers the potential for improved consistency in manufacturing, lower infusion volume, and improv...
Autores principales: | McVoy, Michael M., Tenorio, Edgar, Kauvar, Lawrence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321246/ https://www.ncbi.nlm.nih.gov/pubmed/30544903 http://dx.doi.org/10.3390/ijms19123982 |
Ejemplares similares
-
2772. HCMV gB Ectodomain Subunit and gB mRNA Vaccines Reduce AD-3 Immunodominance and Elicit More Durable Antibody Responses Than gB/MF59 Immunization
por: Nelson, Cody S, et al.
Publicado: (2019) -
Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency
por: Stangherlin, Lucas M., et al.
Publicado: (2017) -
HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
por: Zydek, Martin, et al.
Publicado: (2014) -
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
por: Li, Fengsheng, et al.
Publicado: (2017) -
Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
por: Park, J. W., et al.
Publicado: (2000)